Dr. Rishi Kakar of Segal Institute for Clinical Research Listed as an Author on Research Paper

Segal Institute Logo

Segal Institute for Clinical Research’s Dr. Rishi Kakar helped to author the research paper, “A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies,” which was recently published in Neuropsychopharmacology. Specifically, the paper is centered around a  study that demonstrated that NOP receptors with LY2940094, translate to antidepressant efficacy in patients with major depressive disorder (MDD).


For more on this study, please read below.                                       http://www.businesswire.com/news/home/20160114006254/en


Want more information?

Join our

Be the first to know about our new studies! You can unsubscribe at any time.